PMC:7441788 / 1118-1749
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 162-170 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T14 | 257-265 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 372-380 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T16 | 455-463 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T17 | 610-618 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 98-99 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T13 | 61-63 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T14 | 100-109 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T15 | 234-236 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T16 | 348-350 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T17 | 430-441 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T18 | 445-447 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 61-63 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T11 | 100-109 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T12 | 234-236 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T13 | 348-350 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T14 | 445-447 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T11 | 162-170 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T12 | 257-265 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T13 | 372-380 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T14 | 455-463 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T15 | 610-618 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T14 | 11-171 | Sentence | denotes | However, recent studies indicated that the use of CQ/HCQ, alone or in combination with a macrolide, did not show any favorable effect on patients with COVID-19. |
| T15 | 172-275 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
| T16 | 276-567 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
| T17 | 569-571 | Sentence | denotes | 1. |
| T18 | 573-585 | Sentence | denotes | Introduction |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 120 | 610-618 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 46 | 148-156 | Species | denotes | patients | Tax:9606 |
| 47 | 266-274 | Species | denotes | patients | Tax:9606 |
| 55 | 61-67 | Chemical | denotes | CQ/HCQ | |
| 56 | 100-109 | Chemical | denotes | macrolide | MESH:D018942 |
| 57 | 234-236 | Chemical | denotes | CQ | MESH:D002738 |
| 58 | 237-240 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 348-350 | Chemical | denotes | CQ | MESH:D002738 |
| 60 | 351-354 | Chemical | denotes | HCQ | MESH:D006886 |
| 61 | 445-447 | Chemical | denotes | CQ | MESH:D002738 |
| 62 | 448-451 | Chemical | denotes | HCQ | MESH:D006886 |
| 70 | 162-170 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 71 | 257-265 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 72 | 372-380 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 73 | 455-463 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 598-605 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T11 | 162-170 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 257-265 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T13 | 372-380 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T14 | 455-463 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 586-608 | Disease | denotes | Coronavirus disease-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T16 | 610-618 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 199-220 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 46 | 148-156 | Species | denotes | patients | Tax:9606 |
| 47 | 266-274 | Species | denotes | patients | Tax:9606 |
| 55 | 61-67 | Chemical | denotes | CQ/HCQ | |
| 56 | 100-109 | Chemical | denotes | macrolide | MESH:D018942 |
| 57 | 234-236 | Chemical | denotes | CQ | MESH:D002738 |
| 58 | 237-240 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 348-350 | Chemical | denotes | CQ | MESH:D002738 |
| 60 | 351-354 | Chemical | denotes | HCQ | MESH:D006886 |
| 61 | 445-447 | Chemical | denotes | CQ | MESH:D002738 |
| 62 | 448-451 | Chemical | denotes | HCQ | MESH:D006886 |
| 70 | 162-170 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 71 | 257-265 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 72 | 372-380 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 73 | 455-463 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 119 | 586-608 | Disease | denotes | Coronavirus disease-19 | MESH:C000657245 |
| 120 | 610-618 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T14 | 11-171 | Sentence | denotes | However, recent studies indicated that the use of CQ/HCQ, alone or in combination with a macrolide, did not show any favorable effect on patients with COVID-19. |
| T15 | 172-275 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
| T16 | 276-567 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
| T17 | 569-571 | Sentence | denotes | 1. |
| T18 | 573-585 | Sentence | denotes | Introduction |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 199-220 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |